ArticleContemporary oncology (Poznan, Poland)2017

Phase II study of adjuvant docetaxel and carboplatin with/without doxorubicin and cyclophosphamide in triple negative breast cancer: a randomised controlled clinical trial.

Safa Najafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.